主动脉夹层治疗后有意靶向封闭假腔:文献系统综述
本系统综述检索MEDLINE、CENTRAL和Cochrane数据库,纳入报告慢性B型主动脉夹层(cTBAD)或A型主动脉夹层(TAAD)治疗后靶向假腔封闭的研究,共101例患者接受血管内手术,技术成功率100%,TAAD30天死亡率为2.5%(1/40),cTBAD为0%,随访2至63个月。作者认为靶向假腔封闭似乎是一种可行的微创方法,但尚未广泛使用,未来需更大样本更长随访的研究。
要点
- 共101例患者接受靶向假腔封闭,其中TAAD 40例、cTBAD 61例,技术成功率100%。
- TAAD组30天死亡率为2.5%(1/40),cTBAD组为0%。
- 随访2至63个月,TAAD组死亡率为0%(0/31),cTBAD组为7.1%(4/61)。
核心结论
- 作者认为,靶向假腔封闭似乎是cTBAD或TAAD治疗后一种可行的微创方法,但尚未广泛使用。
- 作者指出,未来更大样本、更长随访的研究可能显示其在主动脉重塑或稳定疾病进展方面的明显获益。
研究设计与样本
- 系统综述,遵循PRISMA规范,检索MEDLINE、CENTRAL和Cochrane数据库,纳入报告cTBAD或TAAD治疗后靶向假腔封闭的研究。
- 共纳入101例患者,其中TAAD开放修复术后40例(3篇病例报告和3项回顾性研究),cTBAD 61例(13篇病例报告和6项回顾性研究),2项研究同时报告了两种手术。
主要发现
- TAAD患者中27/40(68%)有既往开放修复史,cTBAD患者中48/61(79%)有既往血管内修复史。
- TAAD患者31例(78%)和cTBAD患者51例(83%)为择期治疗。
- 使用四种主要技术:candy-plug(19/101)、knickerbocker(3/91)、「瓶颈中的软木塞」技术(2/101)以及联合使用弹簧圈、onyx、封堵器和胶的假腔栓塞(77/101)。
- 技术成功率为100%,30天死亡率TAAD为2.5%(1/40),cTBAD为0%。
- 随访(范围2至63个月)期间,死亡率TAAD为0%(0/31),cTBAD为7.1%(4/61);假腔完全血栓化TAAD为78%(31/40),cTBAD为62%(38/61),部分血栓化分别有3例和2例(22例无报告)。
局限性
- 作者指出,靶向假腔封闭尚未广泛使用。
- 作者指出,未来需更大样本、更长随访的研究来证明其获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Residual patent false lumen (FL) after chronic type B aortic dissection (cTBAD) or type A aortic dissection (TAAD) treatment is independently associated with poor long-term outcomes. The aim of our study was to present endovascular techniques and the existing experience with targeted FL thrombosis after cTBAD or TAAD treatment. MATERIAL AND METHODS: A systematic review was performed (Preferred Reporting Items for Systematic reviews and Meta-Analyses) searching in MEDLINE, CENTRAL, and Cochrane databases for studies reporting on targeted FL occlusion after cTBAD or TAAD treatment. RESULTS: One hundred one patients either after open repair of a TAAD (n = 40; 3 case reports and 3 retrospective studies) or after cTBAD (n = 61; 13 case reports and 6 retrospective studies) underwent an endovascular procedure for intentional FL occlusion (2 studies reported on both procedures). Among TAAD patients, 27 of 40 (68%) had previous open repair, whereas 48 of 61 (79%) with cTBAD had a previous endovascular repair. Thirty-one (78%) patients with TAAD and fifty-one (83%) with cTBAD were treated electively. Four main techniques were used: (1) the candy-plug (19/101), (2) the knickerbocker (3/91), (3) the "cork in the bottle neck" technique (2/101), and (4) FL embolization with combined use of coils, onyx, plugs, and glue (77/101). The technical success rate was 100%, with a 30-day mortality rate of 2.5% (1/40) in TAAD and 0% in cTBAD patients. During follow-up (ranging: 2 to 63 months), the mortality rate was 0% (0/31) and 7.1% (4/61) in TAAD and cTBAD patients, respectively. The FL remained completely thrombosed in 78% (31/40) of TAAD and 62% (38/61) of cTBAD patients, whereas it was partially thrombosed in 3 and 2 patients, respectively (no report for 22 patients). CONCLUSIONS: Intentional FL occlusion seems to be a feasible less invasive approach after cTBAD or TAAD treatment, which is not broadly used. Future larger studies with longer follow-up duration may demonstrate the apparent benefit in terms of aortic remodeling or stabilization of the disease progression.
引用
- Spanos K, Kölbel T, Rohlffs F, et al. Intentional Targeted False Lumen Occlusion after Aortic Dissection: A Systematic Review of the Literature. Ann Vasc Surg. 2018. PMID: 30496905. doi:10.1016/j.avsg.2018.08.086
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。